Stay updated on Cabozantinib for NSCLC Brain Metastases Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib for NSCLC Brain Metastases Clinical Trial page.

Latest updates to the Cabozantinib for NSCLC Brain Metastases Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedSite revision updated from v3.4.3 to v3.5.0. No visible changes to the study details page or layout.SummaryDifference0.1%

- Check25 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3. No user-facing changes to study details or page functionality are introduced.SummaryDifference0.1%

- Check40 days agoChange DetectedNo substantive content changes were detected. The page appears to have only visual/layout adjustments without altering study details.SummaryDifference0.1%

- Check54 days agoChange DetectedThe page now shows Revision: v3.4.2 and the older notices about funding and v3.4.1 have been removed; these are administrative updates that do not affect the trial’s content or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check61 days agoChange DetectedAdded a government funding notice banner and updated the site revision from v3.4.0 to v3.4.1. Both changes are administrative and do not alter study content or user-facing functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check68 days agoChange DetectedGlossary toggle added and capitalization fixes for labels, such as 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data,' plus the site revision banner updated to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Cabozantinib for NSCLC Brain Metastases Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib for NSCLC Brain Metastases Clinical Trial page.